학술논문
PSS12 COST-EFFECTIVENESS ANALYSIS OF BEVACIZUMAB AND RANIBIZUMAB IN NEOVASCULARAGE-RELATED MACULAR DEGENERATION (AMD): A CLINICAL AND ECONOMIC COMPARISON OF TWO VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR TREATMENTS
Document Type
Abstract
Author
Source
In Value in Health 2008 11(3):A288-A288
Subject
Language
ISSN
1098-3015